Free access
1 September 1997

Evaluation of antibodies reactive with Campylobacter jejuni in Egyptian diarrhea patients

Abstract

Serum and stool samples were collected from 128 individuals: 96 diarrhea patients and 32 apparently healthy controls. Stool specimens were cultured for enteric bacterial pathogens, while sera were screened by enzyme-linked immunosorbent assay for Campylobacter jejuni-reactive antibodies. Of 28 diarrhea patients who demonstrated C. jejuni-reactive antibodies (titers, > 100), 14 were culture positive for this organism. The 32 healthy controls showed significantly lower antibody titers (P < 0.05) with the exception of 10 subjects who were culture positive for C. jejuni and had reactive immunoglobulin M (IgM) (6 subjects) and IgG (7 subjects). IgA was not detected in those 10 individuals (asymptomatic). Avidity was expressed as the thiocyanate ion concentration required to inhibit 50% of the bound antibodies. The avidity was higher in symptomatic patients than asymptomatic healthy controls. IgG was less avid (0.92 M) compared to IgM (0.1 M) and IgA (1.1 M), with no correlation between antibody titer and avidity. However, the thiocyanate ion concentration required for the complete inhibition of IgG (5 M)-bound antibodies was higher than that of IgA (2 M) and IgM (3 M). This study also shows that C. jejuni antibodies were variably cross-reactive with Escherichia coli, Shigella flexneri, Shigella sonnei, and Neisseria meningitidis in addition to Campylobacter coli and Campylobacter rectus.

Formats available

You can view the full content in the following formats:

Information & Contributors

Information

Published In

cover image Clinical Diagnostic Laboratory Immunology
Clinical Diagnostic Laboratory Immunology
Volume 4Number 5September 1997
Pages: 536 - 539
PubMed: 9302201

History

Published online: 1 September 1997

Permissions

Request permissions for this article.

Contributors

Authors

T F Ismail
U.S. Naval Medical Research Unit No. 3, Cairo, Egypt. [email protected]
M O Wasfy
U.S. Naval Medical Research Unit No. 3, Cairo, Egypt. [email protected]
B A Oyofo
U.S. Naval Medical Research Unit No. 3, Cairo, Egypt. [email protected]
M M Mansour
U.S. Naval Medical Research Unit No. 3, Cairo, Egypt. [email protected]
H M El-Berry
U.S. Naval Medical Research Unit No. 3, Cairo, Egypt. [email protected]
A M Churilla
U.S. Naval Medical Research Unit No. 3, Cairo, Egypt. [email protected]
S S Eldin
U.S. Naval Medical Research Unit No. 3, Cairo, Egypt. [email protected]
L F Peruski, Jr
U.S. Naval Medical Research Unit No. 3, Cairo, Egypt. [email protected]

Metrics & Citations

Metrics

Note: There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.

Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

View Options

Figures and Media

Figures

Media

Tables

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy